[{"status": "Terminated", "city": "Rochester", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018261"], "brand_name": ["PITOCIN"], "generic_name": ["OXYTOCIN"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["42023-116"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["OXYTOCIN"], "rxcui": ["207315", "238013", "1791721", "1791723"], "spl_id": ["e00f2acb-4c77-41a3-ae91-61f8356233ef"], "spl_set_id": ["969d5b35-0add-4c23-9605-6a5b6ab65c95"], "package_ndc": ["42023-116-25", "42023-116-01", "42023-116-02"], "is_original_packager": [true], "nui": ["N0000009705", "N0000175828", "M0015703"], "pharm_class_pe": ["Increased Uterine Smooth Muscle Contraction or Tone [PE]"], "pharm_class_epc": ["Oxytocic [EPC]"], "pharm_class_cs": ["Oxytocin [CS]"], "unii": ["1JQS135EYN"]}, "product_type": "Drugs", "event_id": "62013", "recalling_firm": "JHP Pharmaceuticals, LLC", "address_1": "870 Parkdale Rd", "address_2": "", "postal_code": "48307-1740", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1420-2012", "product_description": "Pitocin (Oxytocin Injection, USP) Synthetic 10 units per mL 10 mL, Rx only, Manufactured and Distributed by: JHP Pharmaceuticals, LLC Rochester, MI 48307 NDC 42023-116-02", "product_quantity": "26100 vials", "reason_for_recall": "Labeling: Label Mix-up: Pitocin storage conditions should be labeled, \"Store between 20\u00bf to 25\u00bfC (68\u00bf to 77\u00bfF)\". Pitocin lot 225867 and part of Pitocin lot 231423 were labeled, \"Store between 20\u00bf to 25\u00bfC (28\u00bf to 77\u00bfF)\".", "recall_initiation_date": "20120605", "center_classification_date": "20120716", "termination_date": "20121105", "report_date": "20120725", "code_info": "Lot  231423, 255867", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020742"], "brand_name": ["BSS"], "generic_name": ["BALANCED SALT SOLUTION"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-0795"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM ACETATE", "SODIUM CHLORIDE", "SODIUM CITRATE"], "rxcui": ["806392", "806396"], "spl_id": ["f56f90e2-cd68-445b-b8fb-74a53f0f2ca6"], "spl_set_id": ["4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea"], "package_ndc": ["0065-0795-15", "0065-0795-30", "0065-0795-25", "0065-0795-50"], "is_original_packager": [true], "upc": ["0300650795159"], "unii": ["M4I0D6VV5M", "02F3473H9O", "660YQ98I10", "4550K0SC9B", "451W47IQ8X", "1Q73Q2JULR"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1033-2022", "product_description": "BSS Sterile Irrigating Solution (balanced salt solution), 15 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC 0065-0795-15", "product_quantity": "13 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0253-2017", "product_description": "BiMix Phentolamine/Papaverine 2 mg/30 mg/mL (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 09302016D (11/14/2016)."}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65840", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Canada, and Panama.", "recall_number": "D-906-2013", "product_description": "Maalox Extra Strength Antacid (calcium carbonate) chewable tablets,1000 mg, Wild Berry flavor, packaged in a) 35-count (UPC 0 58478 44829 9) and b) 65-count (UPC 0 58478 44842 8) tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 02238291.", "product_quantity": "149,616 bottles", "reason_for_recall": "Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.", "recall_initiation_date": "20130806", "center_classification_date": "20130820", "termination_date": "20141104", "report_date": "20130828", "code_info": "Lot #: a) 10095535, Exp 07/13; 10101288, Exp 10/13; 10104665, Exp 01/14; 10111114, Exp 02/14; 10114314, Exp 04/14; 10120621, Exp 07/14; b) 10095536, Exp 07/13; 10101289, Exp 10/13; 10104666, Exp 01/14; 10111116, Exp 02/14; 10114315, Exp 04/14; 10120622, Exp 07/14"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0614-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Food Chemical Intolerances, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955504221, NDC 57955-0728-2", "product_quantity": "1326 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 120516A Exp. 12/19; 060316C Exp. 06/19; 010118S Exp. 01/20"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0132-2015", "product_description": "Sodium tetradecyl SO4 stock solution 6% solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "1,300 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 05142014@16, Exp 11/10/2014; 07142014@47, Exp 1/10/2015; 07152014@18, Exp 1/11/2015; 08062014@16, Exp 2/2/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1194-2020", "product_description": "Hydroquinone/Fluocinolone/Tretonoin/Kojic Acid 4/0.01/0.05/2% Cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45077 Discard by: 3/12/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Short Hills", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207427"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Bayshore Pharmaceuticals LLC"], "product_ndc": ["76385-128", "76385-129"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["b6d19df3-bc53-4aa3-b2d3-69dbb95b7c05"], "spl_set_id": ["93c8deae-3103-4cbf-a5d1-fe0d37e76df8"], "package_ndc": ["76385-128-10", "76385-128-01", "76385-128-50", "76385-129-01", "76385-129-50"], "is_original_packager": [true], "upc": ["0376385128104"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "86280", "recalling_firm": "BAYSHORE PHARMACEUTICALS", "address_1": "788 Morris Tpke Ste 200", "address_2": "N/A", "postal_code": "07078-2634", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-1544-2020", "product_description": "Metformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by: Beximco Pharmaceuticals, LTD. 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh   NDC 76385-129-01", "product_quantity": "3984 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20200819", "center_classification_date": "20200825", "termination_date": "20210426", "report_date": "20200902", "code_info": "Lot #18657, Exp. 05/2021"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0139-2025", "product_description": "Primo, Topical Anesthetic gel, Benzocaine 20%, Net Content: 1 oz. (30g), Gluten Free, Manufactured for: Primo Dental Products, 845 Third Avenue, 6th Floor, New York, NY 10022.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-13119", "more_code_info": ""}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave Ste A", "reason_for_recall": "Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule", "address_2": "", "product_quantity": "834 cartons", "code_info": "Lot 152254, exp. 12/31/16, lot 152324, exp. 3/31/17, lot 154833, exp. 5/31/17, lot 162406, exp. 12/31/17", "center_classification_date": "20160902", "distribution_pattern": "Product was distributed in the following states: Nationwide", "state": "OH", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII 10 mg 30 UD Capsules (5 x 6), Rx,  Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-815-25; Blister NDC 68084-815-95", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Amerisource Health Services", "recall_number": "D-1486-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75076", "termination_date": "20171218", "more_code_info": "", "recall_initiation_date": "20160824", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076255"], "brand_name": ["OLANZAPINE"], "generic_name": ["OLANZAPINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Ltd."], "product_ndc": ["55111-163"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLANZAPINE"], "rxcui": ["200034"], "spl_id": ["ba26436d-7009-476f-23b0-45676a0e7805"], "spl_set_id": ["9a57a63e-f856-aafa-037a-c08f2fea6496"], "package_ndc": ["55111-163-30", "55111-163-01", "55111-163-05", "55111-163-79", "55111-163-78"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["N7U69T4SZR"]}, "product_type": "Drugs", "event_id": "75442", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0468-2017", "product_description": "Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30", "product_quantity": "5,904 bottles", "reason_for_recall": "Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.", "recall_initiation_date": "20161013", "center_classification_date": "20170203", "termination_date": "20170724", "report_date": "20170215", "code_info": "C500202"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0615-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Fever Reliever, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955516026, NDC 57955-5160-2", "product_quantity": "285 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022417H Exp. 02/20; 030216D Exp. 03/19; 052616J Exp. 05/19; 092815B Exp. 09/18"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0064-2018", "product_description": "morphine sulfate 1 mg per mL in 0.9% Sodium Chloride  a) Total Volume 100 mL in Single Dose CADD Cassette (Total morphine Dose 100 mg per 100 mL) (NDC 70004-0100-63) b) Total Volume 50 mL in Single Dose Syringe (Total morphine Dose 50 mg / 50 mL) (NDC 70004-0100-22) Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205", "product_quantity": "a) 60 bag inside rigid translucent plastic case (CADD)  b) 238 bag", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lots: a) 20170905@24 BUD: 12/04/2017 b) 20170901@25 BUD: 11/30/2017"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-054-2014", "product_description": "Betamethasone NA Phosphate (PF) 6mg/ml 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; OXcarbazepine Tablet, 600 mg may be potentially mislabeled as    LACTASE ENZYME, Tablet, 3000 units, NDC 24385014976, Pedigree: AD30028_25, EXP: 5/7/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "OXcarbazepine, Tablet, 600 mg has the following code    Pedigree: AD30140_46, EXP: 5/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OXcarbazepine Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62756018588", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-674-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0460-2018", "product_description": "Labetalol HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0365-2017", "product_description": "Methylcobalamin 1,000 mcg/mL Injectable, a) 10 mL vial and b) 30 mL vial,  Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 499 vials b) 1214 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04062016@5, 05172016@1, 06162016@2, 07202016@47, 08222016@6    b) Known lot code: 04052016@1, 05032016@1, 05182016@1, 05262016@32, 06162016@13, 06232016@74, 07012016@18, 08092016@6, 09062016@33"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "99 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03312015@18, 5/30/2015; 03252015@49, 5/24/2015; 04012015@60 5/31/2015; 05112015@59, 7/10/2015; 04062015@39, 6/5/2015; 04072015@25, 6/6/2015; 04072015@74, 6/6/2015; 04142015@44, 6/13/2015; 04172015@72, 6/16/2015; 04172015@77, 6/16/2015; 04232015@8, 6/22/2015; 04222015@60, 6/21/2015; 04242015@11, 6/23/2015; 04292015@33, 6/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 2,500 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1528-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0407-2017", "product_description": "Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL,  a) 2 mL  and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 257 vials and b) 460 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04072016@10, 05102016@18, 06232016@12, 08182016@26    b) Known lot code: 04122016@19, 05042016@18, 06142016@43, 07122016@40, 07262016@47."}, {"status": "Terminated", "city": "Whitehouse Station", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67344", "recalling_firm": "Merck & Co Inc", "address_1": "1 Merck Dr", "address_2": "P.O. Box 100", "postal_code": "08889-3400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1310-2014", "product_description": "Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister    (NDC 66582-321-30), b) 90 count blister  (NDC 66582-321-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station, NJ 08889", "product_quantity": "20,259 cartons", "reason_for_recall": "This recall of LIPTRUZET is being initiated due to  packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.", "recall_initiation_date": "20140113", "center_classification_date": "20140506", "termination_date": "20150902", "report_date": "20140514", "code_info": "a) Liptruzet 10/20mg 30 count, 346353, 346354, Exp. 06/14; 351809, Exp. 07/14, 360530, Exp. 12/14.   b) Liptruzet 10/20mg,  90 count,  346387, Exp. 06/14; 353185, Exp.12/14."}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0482-2025", "product_description": "Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "24 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot, expiry:   H272962, exp 12/5/2025; S5045185, exp 5/20/2025;  H272962, exp 12/5/2025;  H270625, exp 9/30/2025", "more_code_info": ""}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018916"], "brand_name": ["HEPARIN SODIUM"], "generic_name": ["HEPARIN SODIUM"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1005", "0409-7620", "0409-2222"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HEPARIN SODIUM"], "rxcui": ["1658690", "1658692"], "spl_id": ["c38c96a5-ff8a-43b6-a598-dfd044719d89"], "spl_set_id": ["32e34077-aff1-4ec7-f9b0-b8e240768fb8"], "package_ndc": ["0409-7620-13", "0409-7620-03", "0409-7620-49", "0409-7620-59", "0409-1005-01", "0409-1005-20", "0409-2222-01", "0409-2222-12"], "is_original_packager": [true], "unii": ["ZZ45AB24CA"]}, "product_type": "Drugs", "event_id": "91379", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0097-2023", "product_description": "Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,", "product_quantity": "62,088 bags", "reason_for_recall": "Lack of assurance of sterility: Bags have the potential to leak.", "recall_initiation_date": "20221229", "center_classification_date": "20230105", "report_date": "20230111", "code_info": "Lot: 5935283, Exp. 12/01/2023"}, {"status": "Terminated", "city": "Holbrook", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65676", "recalling_firm": "Braintree Laboratories Inc.", "address_1": "270 Centre St", "address_2": "N/A", "postal_code": "02343-1073", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwie", "recall_number": "D-911-2013", "product_description": "Braintree HalfLytely and Bisacodyl Tablet Bowel Prep Kit (Rx)   NDC 52268-523-02", "product_quantity": "10,362 kit cartons", "reason_for_recall": "Defective Container; Small micro fracture observed in the 2-Liter bottle at the fill line resulting in a small leak when patient reconstitutes the bulk powder", "recall_initiation_date": "20130715", "center_classification_date": "20130820", "termination_date": "20140121", "report_date": "20130828", "code_info": "Lot 3013002 Exp. 08/14"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76513", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States and Puerto Rico", "recall_number": "D-0511-2017", "product_description": "Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.", "product_quantity": "25,916 cartons", "reason_for_recall": "Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.", "recall_initiation_date": "20170217", "center_classification_date": "20170303", "termination_date": "20180205", "report_date": "20170315", "code_info": "Lot # 34025762A, Exp 06/17"}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0726-2018", "product_description": "PYRIDOXINE Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "635 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lots: P/121517 Discard by 6/13/2018; CAP/013118 Discard by 4/1/2018; CAP/020518 Discard by 4/6/2018; CAP/021418 Discard by 4/15/2018; CAP/021918 Discard by 4/20/2018"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["PUBLIX SUPER MARKETS, INC."], "product_ndc": ["56062-266"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["38405419-9aa6-e46b-e063-6294a90ad28b"], "spl_set_id": ["267c434d-3034-491b-b4b1-1d0cbacb1615"], "package_ndc": ["56062-266-38"], "is_original_packager": [true], "upc": ["0041415506732", "041415506732"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1505-2022", "product_description": "P, magnesium citrate SALINE LAXATIVE, Oral Solution, (1.745 g/fl oz), Lemon Flavor, 10 FL OZ (296 mL), Distributed By Publix Super Markets, Inc. 3300 Publix Corporate Parkway, Lakeland, FL 33811; NDC 56062-266-38 UPC 0 41415 50673 2", "product_quantity": "8,682 bottles", "reason_for_recall": "Microbial contamination of non-sterile products.", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "Lot # 0562243, EXP 2/17/2024", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0383-2020", "product_description": "CVS Health Preservative Free Lubricant Eye Drops, 60 Sterile Single-Use Containers, 0.02 FL OZ (0.6 mL) EACH,  Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "39072 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: RGF 07/19  RHN 08/19  RIH 09/19  RJP 10/19  RKN 11/19  SDC 04/20  SFC 06/20  SFJ 06/20  SGI 07/20  SKF 11/20  TAE 01/21"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0697-2019", "product_description": "Dr. King's SafeCare Rx Soothing Advanced Arnica Pure Homeopathic Cream High Potency Homeopathic Formula for Professional Use Only, 3 oz. (85 g), King Bio, Inc., 3 Westside Drive Asheville, NC 28806 USA, UPC 357955730132, NDC 57955-7301-3", "product_quantity": "3536 tubes", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 010517ZZ Exp. 01/20; 030818ZZ Exp. 03/21; 040617ZZ Exp. 04/20; 100616ZZ Exp. 05/19; 110916ZZ Exp. 11/19"}, {"status": "Terminated", "city": "Philadelphia", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70711", "recalling_firm": "Mutual Pharmaceutical Company,  Inc.", "address_1": "1100 Orthodox St", "address_2": "", "postal_code": "19124-3168", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0414-2015", "product_description": "Ergoloid Mesylates ,1 mg tablets, 100 count bottle, Rx only,  Manufactured by MUTUAL PHARMACEUTICAL CO., INC., PHILADELPHIA, PA 19124 USA for Sun Pharmaceutical Industries, Inc. 270 Prospect Plains Road, Cranbury, NJ 08512. NDC  53489-281-01", "product_quantity": "23246 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: during long-term stability testing.", "recall_initiation_date": "20150310", "center_classification_date": "20150316", "termination_date": "20160715", "report_date": "20150325", "code_info": "Lot #: 6557301, Exp 3/15;  6557401, Exp 3/15;  6557501, Exp 3/15;  6656301, Exp 10/16; 6687701, Exp 4/17.", "more_code_info": ""}, {"status": "Terminated", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75164", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS", "recall_number": "D-1541-2016", "product_description": "Autologous Serum Tears, 2 vials, Rx, Vital Care Compounder, Hattiesburg, MS 39402", "product_quantity": "8 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160726", "center_classification_date": "20160927", "termination_date": "20161118", "report_date": "20161005", "code_info": "Lot#:  390325, Use by 08/01/16; 382789, Use by 08/07/16; 396766, Use by 08/11/16; 393470, Use by 08/14/16; 393036, Use by 08/14/16; 398131, Use by 08/15/16; 389288, Use by 08/20/16; 392969, Use by 08/21/16"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90551", "recalling_firm": "Loud Muscle Science", "address_1": "300 Oser Ave", "address_2": "N/A", "postal_code": "11788-3608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "The product was distributed nationwide in the USA and Canada.", "recall_number": "D-1337-2022", "product_description": "Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.", "product_quantity": "1000 10-count tins", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20220627", "center_classification_date": "20220815", "termination_date": "20230208", "report_date": "20220727", "code_info": "Lot # 2022104, Exp. Date 04/2025"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0812-2019", "product_description": "Dr. King's SafeCare Rx Personality Changes, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955105022, NDC 57955-1053-2", "product_quantity": "13 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 051716F Exp. 05/19"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t11-16-2016@90, Exp 4/19/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PGE1/PAP 10/30 5ML MDV MCG/MG/ML INJ, Injection,  10mg/30mg/mL, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0734-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t01-05-2017@110, Exp 6/17/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "QUAD MIX 1/30/0.5/0.1 5ML MDV MCG/MG/MG/MG/ML INJ, Injection, 1mcg/30mg/0.5mg/0.15mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0754-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "94 cases", "code_info": "Product Code: 6004; Lots: 61610, EXP 11/17/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Independent Care System Corinz, Contains: 1.5 fl oz bottle Corinz Mouthwash, 0.5 oz/14g tube of Mouth Moisturizer, 0.3 oz/9g tube of Sodium Bicarbonate Mouthpast, 1 Ultra-Soft toothbrush. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6004 UPC 6 18029 82148 5", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0362-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91786", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0458-2023", "product_description": "Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0704-01), b) 500-count bottle and c) 1,000-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Potential risk of Cross Contamination", "recall_initiation_date": "20230302", "center_classification_date": "20230310", "termination_date": "20240321", "report_date": "20230322", "code_info": "Lot #a) 5210734, Exp 4/30/2023; 5211451, Exp 8/31/2024; 5220529, Exp 4/30/2025; b) 5210735, Exp 4/30/2023; 5210736, Exp 4/30/2023, 5210993, Exp 5/31/20; 5210994, Exp 5/31/2023, 5211100, Exp 6/30/2023, 5211452, Exp 8/31/2024, 5211453, Exp 8/31/2024, 5211454, Exp 8/31/2024, 5211640, Exp 10/31/2024, 5211641, Exp 10/31/2024; c) 5210737, Exp 4/30/2023; 5210995, Exp 5/31/2023; 5211101, Exp 6/30/2023, 5211269, Exp 7/31/2024,  5211270, Exp 7/31/2024, 5211271, Exp 7/31/2024."}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2218 mL in Vials", "code_info": "a) Lot #: 151217-2, BUD: 05/30/16;  Lot #: 160115-6, BUD: 05/30/16;  Lot #: 160303-8, BUD: 08/30/16;  Lot #: 160303-10, BUD: 08/30/16.  b) Lot #: 151203-37, BUD: 05/30/16;  Lot #: 151203-72, BUD: 05/30/16;  Lot #: 151209-7, BUD: 05/30/16;  Lot #: 151209-8, BUD: 05/30/16;  Lot #: 151209-9, BUD: 05/30/16;  Lot #: 151209-10, BUD: 05/30/16;  Lot #: 151209-11, BUD: 05/30/16;  Lot #: 151209-13, BUD: 05/30/16;  Lot #: 151209-14, BUD: 05/30/16;  Lot #: 160104-31, BUD: 05/30/16;  Lot #: 160113-77, BUD: 05/30/16;  Lot #: 151218-7, BUD: 06/15/16;  Lot #: 151218-8, BUD: 06/15/16;  Lot #: 160113-78, BUD: 07/11/16;  Lot #: 160113-4, BUD: 07/11/16;  Lot #: 160122-10, BUD: 07/20/16;  Lot #: 160201-6, BUD: 07/30/16;  Lot #: 160201-7, BUD: 07/30/16;  Lot #: 160204-9, BUD: 08/02/16;  Lot #: 160208-5, BUD: 08/06/16;  Lot #: 160208-6, BUD: 08/06/16;  Lot #: 160210-65, BUD: 08/08/16;   Lot #: 160210-66, BUD: 08/08/16;  Lot #: 160210-67, BUD: 08/08/16;  Lot #: 160210-68, BUD: 08/08/16;  Lot #: 160210-69, BUD: 08/08/16;  Lot #: 160303-12, BUD: 08/30/16;  Lot #: 160303-13, BUD: 08/30/16;  Lot #: 160309-2, BUD: 09/05/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "DMSO 99.9 (PF), In a)  5ML Vials and b) 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1181-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0268-2015", "product_description": "HCG 200 IU/mL Injection, 30Ml, 10 mL vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-7745-68", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141015DD, 11/15/14", "more_code_info": ""}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA213510"], "brand_name": ["DOCETAXEL"], "generic_name": ["DOCETAXEL ANHYDROUS"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-254"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOCETAXEL ANHYDROUS"], "rxcui": ["1093280"], "spl_id": ["841e3024-e160-4c4b-93d3-1e79d628d95b"], "spl_set_id": ["6b227144-c844-4549-960c-cc3ac5c13b2b"], "package_ndc": ["25021-254-08", "25021-254-16"], "is_original_packager": [true], "nui": ["N0000175085", "N0000175592"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "unii": ["699121PHCA"]}, "product_type": "Drugs", "event_id": "94707", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0554-2024", "product_description": "Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08", "product_quantity": "2806 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.", "recall_initiation_date": "20240528", "center_classification_date": "20240612", "report_date": "20240619", "code_info": "Lot #: F1030001, Exp. Date 12/31/2024"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1199-2014", "product_description": "Pleo Nota- Quent DROPS 5X, 10 mL Bottles, Homeopathic Medicine, OTC Only.  Made in Germany, Manufactured by: Sanum-Kehlbeck GmbH & Co. KG, Hoya, Germany.  Distributed by: SANUM USA Corp., 1465 Slater Road, Ferndale, WA 98248. NDC: 49807-0031-1.", "product_quantity": "6120 cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch #04062 , EXP: May 2017; Batch #06062 , EXP: May 2017."}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0263-2015", "product_description": "Phenylephrine HCl (100 mcg/mL syr) in 0.9% NaCl 1 mg / 10 mL, 3Ml Syringes, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-5230-12", "product_quantity": "8 prefilled syringes", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141008AA, 11/8/14; 141017E, 11/17/14; 141030EE, 11/30/14", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090710"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["57664-228", "57664-229", "57664-230"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091150", "1091392", "1091497"], "spl_id": ["2f1c1df8-491a-08c9-e063-6394a90a1d06"], "spl_set_id": ["1a89b390-0cd5-45cb-9e70-20de44652c56"], "package_ndc": ["57664-228-83", "57664-228-88", "57664-228-08", "57664-228-13", "57664-228-18", "57664-229-83", "57664-229-88", "57664-229-08", "57664-229-13", "57664-229-18", "57664-230-83", "57664-230-88", "57664-230-08", "57664-230-13", "57664-230-18"], "is_original_packager": [true], "upc": ["0357664228883", "0357664229880", "0357664230886"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "92680", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0940-2023", "product_description": "Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.", "product_quantity": "7313 bottles", "reason_for_recall": "Presence of Foreign Substance: Metal embedded in a tablet.", "recall_initiation_date": "20230713", "center_classification_date": "20230724", "termination_date": "20240212", "report_date": "20230802", "code_info": "Lot AC74459, Exp 07/31/2024"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "48,003 cases", "code_info": "Product Code: 6912; Lots: 52736, 52807, 52878, 52994, 53067, 53084, 53137, 53192, EXP 08/31/2017; 53363, 53459, 53695, 53748, 53868, EXP 9/30/2017; 53916, 54003, 54011, 54012, 54015, 54024, 54049, 54057, 54265, 54279, 54293, EXP 10/31/2017; 54487, 54562, 54613, EXP  12/31/2017; 54686, 54703, 54736, 54745, 54748, 54751, 54817, 54979, 55047, EXP 11/30/2017; 55546, 55561, 55580, 55589, 55602, 55615, 55680, 55709, 55718, 55726, 55735, 55740, 55843, 55857, 55868, 55880, 55900, 55960, EXP 12/31/2017; 56348, 56418, 56604, 56670, 56820, 56944, 56975, 57140, 57201, EXP 02/28/2018; 57506, 57579, 57733, 57900, EXP 03/31/2018; 57925, 58229, 58281, EXP 04/30/2018; 58696, 58762, 59044, EXP 6/30/2018; 59456, 59546, EXP 7/31/2018; 59766, 59830, 60293, 60358, EXP 8/31/2018; 60416, 60563, 60623, 60983, EXP 9/30/2018; 61780, 62118, EXP 12/13/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "QCare Rx Oral Cleansing and Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse q2. Contains: 1 Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse, 4  Suction Oral Swab packages with Perox-A-Mint Solution, 6 Suction Oral Swab packages with Alcohol-Free Mouthwash, 4 Oropharyngeal Suction Catheter packages.  Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013 Product Code 6912 UPC 6 18029 83016 6", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0352-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; metFORMIN HCl Tablet, 500 mg may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD32742_1, EXP: 5/1/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "metFORMIN HCl, Tablet 500 mg has the following code    Pedigree: AD46312_25, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "metFORMIN HCl Tablet 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155010201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-528-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Jewett", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71187", "recalling_firm": "Bee Extremely Amazed LLC", "address_1": "85205 Sportsmans Club Rd", "address_2": "N/A", "postal_code": "43986-9794", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1143-2016", "product_description": "La' Trim Plus Capsules, 350 mg,  60-count bottles, Manufactured for: MWN Health 37 N Orange Ave Suite 500 Orlando, FL 32801 (407) 930-4043", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.", "recall_initiation_date": "20151215", "center_classification_date": "20160706", "termination_date": "20200423", "report_date": "20160713", "code_info": "All lots"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1450-2020", "product_description": "Tasty Drops Hemp Oil Extract, Vanilla, 1 FL. OZ (30ML) bottles, 300MG CBD, Dist by: Tasty Hemp Oil, Jenison, MI, UPC 8 02991 76471 4", "product_quantity": "104 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003126", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-466-2015", "product_description": "Bayshore Medical Center (TX) 5% Dextrose Starter Neo TPN, Trophamine 2.4% , Dextrose 5%, Additives: heparin PF 1 unit(s)/ml, Calcium Gluconate 2.3mEq/dL, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "3 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74775, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74775-0-3-R, Disp ID: 37-1124582"}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0898-2016", "product_description": "Happy Passengers, packaged in BIG BOX (30 small boxes / 1 capsule per box / 30 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0108-2020", "product_description": "Cyclopentolate HCl 1% (10 mg/mL) / Phenylephrine HCl 2.5% (25 mg/mL) / Tropicamide 1% (10 mg/mL) / Ketorolac Tromethamine 0.5% (5 mg/mL), 3 mL Droptainer, Sterile Ophthalmic Topical Solution, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676225", "product_quantity": "649 droptainers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Conway", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82969", "recalling_firm": "Synthetopes Inc", "address_1": "216 Earnhardt St", "address_2": "N/A", "postal_code": "29526-8287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1404-2019", "product_description": "Sn-DTPA Kit 10 mg, DTPA, Not for Direct Injection, Store at Room Temperature, Synthetopes, Inc.", "product_quantity": "82 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20190528", "center_classification_date": "20190620", "termination_date": "20201015", "report_date": "20190619", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7", "code_info": "Rx # 29038, Exp 05/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 486 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, RX # 29038, Discard After 05/20/2014", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1459-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70465", "recalling_firm": "AnazaoHealth Corporation", "address_1": "7465 W Sunset Rd Ste 1200", "address_2": "N/A", "postal_code": "89113-1944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D0384-2015", "product_description": "Compounded Plaquex, intravenous injection, 50 ML vial.   Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.", "product_quantity": "51 vials", "reason_for_recall": "Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.", "recall_initiation_date": "20150126", "center_classification_date": "20150209", "termination_date": "20150209", "report_date": "20150218", "code_info": "Lot #:  112614-1MC-82186 Exp 5/26/2015; 112614-1MC-82187 Exp 5/26/2015; 112614-1MC-82188 Exp 05/26/205 ;112614-1MC-82189 Exp 5/26/2015"}, {"status": "Terminated", "city": "Monmouth Junction", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81960", "recalling_firm": "Tris Pharma Inc.", "address_1": "2033 US Highway 130", "address_2": "N/A", "postal_code": "08852-3003", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "One distributor who further distributed Nationwide in the USA.", "recall_number": "D-0494-2019", "product_description": "infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24.", "product_quantity": "35,328 bottles", "reason_for_recall": "Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.", "recall_initiation_date": "20190115", "center_classification_date": "20190214", "termination_date": "20230329", "report_date": "20190220", "code_info": "Lot#: 00717005A, Exp 02/19"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "A5025 Exp 6/2/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Xylazine 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-795-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Seattle", "state": "WA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90627", "recalling_firm": "Amazon.com, Inc.", "address_1": "2021 7th Ave", "address_2": "N/A", "postal_code": "98121-2601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the U.S.A.", "recall_number": "D-1297-2022", "product_description": "Artri King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por:  PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B084KSV12L, UPC 7 501031 111190", "product_quantity": "15,087 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.", "recall_initiation_date": "20220526", "center_classification_date": "20220727", "termination_date": "20221108", "report_date": "20220727", "code_info": "Lot #: LTARTKNGOMG30720, Exp. Diciembre 2026 (December 2026)"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091569"], "brand_name": ["AMOXICILLIN AND CLAVULANATE POTASSIUM"], "generic_name": ["AMOXICILLIN AND CLAVULANATE POTASSIUM"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-501", "65862-502", "65862-503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN", "CLAVULANATE POTASSIUM"], "rxcui": ["562251", "562508", "617296"], "spl_id": ["2b91e9f8-c77e-4330-8fc1-e574758f0db6"], "spl_set_id": ["ffb158a1-83ba-4100-9221-175aa986dc3e"], "package_ndc": ["65862-501-30", "65862-501-05", "65862-502-20", "65862-502-05", "65862-503-20", "65862-503-01"], "is_original_packager": [true], "unii": ["Q42OMW3AT8", "804826J2HU"]}, "product_type": "Drugs", "event_id": "84910", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0852-2020", "product_description": "Amoxicillin and Clavulanate Potassium Tablets, USP, 875 mg/125 mg, 20-count bottles, Distributed by: Aurobindo Pharma USA. Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India; NDC 65862-503-20", "product_quantity": "30432 bottles", "reason_for_recall": "Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie", "recall_initiation_date": "20200207", "center_classification_date": "20200219", "termination_date": "20221117", "report_date": "20200219", "code_info": "Lot #: SM8719040-A, Exp. Date 02/2021", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0547-2016", "product_description": "IVIG Gammagard injection bag, a) 13 gm, b) 20 gm, c) 73 gm, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "5 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90774", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Distributed Nationwide in the USA to the following States: AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, UT", "recall_number": "D-1470-2022", "product_description": "Colgate Whitening Mouthwash, OPTIC WHITE ICY FRESH MINT. 16 fl. OZ. (1 pt) 473 mL UPC 0 35000 67111 0. Dist. by: Colgate-Palmolive Co. New York, NY 10022 U.S.A.", "product_quantity": "840 packages", "reason_for_recall": "cGMP deviation: Product held outside of appropriate temperature storage conditions.", "recall_initiation_date": "20220810", "center_classification_date": "20220829", "report_date": "20220907", "code_info": "SKUs 999043 distributed to Family Dollar retail stores in AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, UT", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "270 syringes", "code_info": "Lot #: a) Betameth combo 6mg/ml lido1% bup 0.5% syr: 13021975, Exp 5/19/2013; b) Betameth Combo/Lidocaine 1%/ Bupivacaine 0.5% Syr: 13012550, Exp 4/25/2013; 130215100, Exp 5/15/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Betamethasone Combination with Lidocaine 1% and Bupivacaine 0.5 % Injection, all strengths and all presentations including a) Betameth combo 6 mg/mL lido 1% bup 0.5% syr; and b) Betameth Combo/Lidocaine 1%/ Bupivacaine 0.5% Syr, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-349-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "37 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04162015@27, 10/13/2015; 04032015@20, 9/30/2015; 04202015@47, 10/17/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydroxyprogesterone Caproate (17-HP) 250 mg/ml Injectable, Multi-Dose Vial, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1560-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "25 vials", "code_info": "Lot # t01-10-2017@115, Exp 7/5/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 20/20/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/20mg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0742-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0214-2015", "product_description": "PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN, 27.7mg/0.45mg/45.45mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "5 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140912@25, discard date: 10/27/2014"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-546-2013", "product_description": "ZoDen PD, Antihistamine, Nasal Decongestant,16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872    NDC 13811-0073-16", "product_quantity": "4811 - 16 ounce bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11CQ012  Exp 02/13; Lot# 12GQ002 Exp. 06/14."}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1201-2019", "product_description": "Prostaglandin Tri-Mix 2.5:7.5:0.25 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0778-2019", "product_description": "Dr. King's SafeCare Rx Hypochondria, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955180029, NDC 57955-1807-2", "product_quantity": "30 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 031016H Exp. 03/19; 103116A Exp. 10/19"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90545", "recalling_firm": "Mylan Pharmaceuticals Inc", "address_1": "5005 Greenbag Rd", "address_2": "", "postal_code": "26501-7124", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-1292-2022", "product_description": "Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV", "product_quantity": "253,200 pens (50,650/5 per packs)", "reason_for_recall": "Labeling: Missing label: Label missing from some prefilled  pens.", "recall_initiation_date": "20220705", "center_classification_date": "20220726", "termination_date": "20240226", "report_date": "20220803", "code_info": "Lot #: BF21002895, Exp. Date Aug 2023", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0484-2022", "product_description": "Headache & Congestion Sinus Relief (acetaminophen 250 mg, phenylephrine HCl 5 mg) 2 tablets per packet, Mfd. for First Aid Direct, Mason, OH 45040,  NDC 42961-0206-02", "product_quantity": "5,741,384 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: 9445, AK9445, K9445, Exp. Date 01/2022; K9486, Exp. Date 02/2022; AK9708, Exp. Date 07/2022; AK9515, Exp. Date 03/2022; K9810, Exp. Date 09/2022; AK9658, Exp. Date 06/2022"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0607-2023", "product_description": "Cefepime for Injection, USP 1 gram per vial, Rx only, Mfg. for: Piramal Critical Care Bethlehem, PA 18017 USA, NDC 66794-209-41", "product_quantity": "41,320 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96552", "recalling_firm": "Chattem Inc", "address_1": "1715 W 38th St", "address_2": "", "postal_code": "37409-1248", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide.", "recall_number": "D-0362-2025", "product_description": "Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2", "product_quantity": "129,240 bottles", "reason_for_recall": "CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit", "recall_initiation_date": "20250326", "center_classification_date": "20250411", "report_date": "20250423", "code_info": "LOT 22L603, EXP: Oct 2025; LOT 378999, EXP: Feb 2027", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88843", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0077-2022", "product_description": "Afassco Pain Free Plus X-STRENGTH PAIN RELIEVER (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 Tablets/package, Packaged in 12,000 Packets/Case, PO# 19540, Mfg. for: Afassco Minden, NV 89423 (Shipping Label)", "product_quantity": "519,600 tablets", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.", "recall_initiation_date": "20211013", "center_classification_date": "20211026", "termination_date": "20220328", "report_date": "20211103", "code_info": "Lot #: 9819, K-9819, exp. date 22-Sep"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "20 mL in Vials", "code_info": "a) Lot #: 160302-71, BUD: 08/29/16.  b) Lot #: 151207-8, BUD: 06/04/16;  Lot #: 160106-34, BUD: 07/04/16;  Lot #: 160208-22, BUD: 08/16/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "TESTOSTERONE CYP 20 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials and b) 3ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1243-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: chlorproMAZINE HCl, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs:  ACYCLOVIR, Tablet, 800 mg, NDC 00093894701, Pedigree: AD70629_1, EXP: 5/29/2014;  TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: AD70625_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "chlorproMAZINE HCl, Tablet, 100 mg has the following codes:   Pedigree: AD70629_4, EXP: 5/29/2014;  Pedigree: AD70700_1, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "chlorproMAZINE HCl, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00832030300.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1015-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1015-2013", "product_description": "BUPRENORPHINE 0.1/0.05 MG/ML CREAM, all configurations,  FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "04252013@12 and 07232013@25", "more_code_info": ""}, {"status": "Terminated", "city": "Pittsburgh", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92347", "recalling_firm": "Alpha Aromatics", "address_1": "294 Alpha Dr", "address_2": "N/A", "postal_code": "15238-2906", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed to one account in NC.", "recall_number": "D-0760-2023", "product_description": "FOAMING HAND SANITIZER, fresh mint scent, 62% alcohol, 1 Gallon / 3.78 Liters bottle, 290 Alpha Drive RIDC industrial Park, Pittsburgh, PA 15238,", "product_quantity": "544  1 gallon bottles", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20230516", "center_classification_date": "20230522", "termination_date": "20240701", "report_date": "20230531", "code_info": "Lot: 2020-013211 and 2020-013629, No EXP date on label."}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0311-2023", "product_description": "NALBUPHINE (a) 1.5MG IN 1.5ML NS, (b) 2.5MG IN 2.5ML NS, SYRINGE, pain, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "31 syringes", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 29, 2022"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Phenylephrine 500mcg/mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0441-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0077-2019", "product_description": "Rexall, Extra Moisturizing No Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) 1 FL OZ (30 mL) bottle, 48/3/1 #12687901 w/ Silo", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1131-2016", "product_description": "All tacrolimus Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry.."}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0338-2022", "product_description": "Health Mart, Fexofenadine Hydrochloride tablets, 24HR, 180mg . Antihistamine     70 count bottle, Distributed by: Mckesson 6555 State Highway 161, Irvine, TX 75039. Made in the Czech Republic, NDC 62011-0233-1, UPC  0 52569 13787 1", "product_quantity": "6,960 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot 0FR0461, Exp 2/25/2022"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1493-2022", "product_description": "CORRECTDOSE Children's PAIN RELIEF & Fever Reducer, Cherry,  (Acetaminophen 160 mg per 5 mL), 2.04 FL.OZ (60mL), packaged in 12-5mL individual doses, Distributed by Correct Dose Inc, Braintree MA 02184. NDC 62320-311-05 UPC 8 60003 67145 0", "product_quantity": "1,464 ampoules", "reason_for_recall": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot # 20096A, EXP Oct. 2022"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "L5012 exp. 11/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Altrenogest 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-696-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1177-2019", "product_description": "Serum Tears 20% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "40 drop containers", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206674"], "brand_name": ["BUPROPION HYDROCHLORIDE (SR)"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Cipla USA Inc.,"], "product_ndc": ["69097-877", "69097-878", "69097-879"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993503", "993518", "993536"], "spl_id": ["a9b85841-5a69-4df1-a22d-3d4cf174e9a6"], "spl_set_id": ["9d2c209b-248e-4e26-9cde-fe0abe4428c1"], "package_ndc": ["69097-877-02", "69097-877-03", "69097-877-07", "69097-877-12", "69097-878-02", "69097-878-03", "69097-878-07", "69097-878-12", "69097-879-02", "69097-879-03", "69097-879-07", "69097-879-12"], "is_original_packager": [true], "upc": ["0369097879037", "0369097878030", "0369097877033"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "79446", "recalling_firm": "InvaGen Pharmaceuticals, Inc.", "address_1": "7 Oser Ave", "address_2": "N/A", "postal_code": "11788-3811", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0619-2018", "product_description": "buPROPion HCl Extended-Release Tablets,   USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03)  and b) 100 count (NDC 69097-878-07) bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788", "product_quantity": "N/A", "reason_for_recall": "Failed Dissolution Specifications; during stability testing", "recall_initiation_date": "20180315", "center_classification_date": "20180404", "termination_date": "20210915", "report_date": "20180411", "code_info": "a)   Lot I1606609 and Lot I1606610 Exp. Date 05/2018;  Lot I1610639 Exp. Date 09/2018    b)   Lot #I1606610 Exp Date 05/2018;  Lot I1607847 and Lot I1607845 Exp Date 06/2018;  Lot I1610639 Exp Date 09/2018"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0231-2023", "product_description": "POLIDOCANOL 50MG/ML (5%) (30ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221025@32", "more_code_info": ""}, {"status": "Terminated", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66099", "recalling_firm": "JCB Labs LLC", "address_1": "7335 W 33rd St N", "address_2": "N/A", "postal_code": "67205-9368", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Guam", "recall_number": "D-1043-2013", "product_description": "Acetylcysteine 20% Solution, Preservative Free, 4 mL Sterile Single Dose Vial, Not for Injection, Sterile Solution For Office Use Only, JCB Laboratories, Wichita, KS.", "product_quantity": "903 vials", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140818", "report_date": "20130925", "code_info": "Lot # 130627@5, Exp 08/26/2013", "more_code_info": ""}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091246"], "brand_name": ["OXACILLIN"], "generic_name": ["OXACILLIN SODIUM"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-146", "25021-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["OXACILLIN SODIUM"], "rxcui": ["1743547", "1743549"], "spl_id": ["bfe80588-e805-420a-af34-6bd5e8635525"], "spl_set_id": ["f3bee4d7-82d8-4e2d-8fc8-4446e6fbf999"], "package_ndc": ["25021-146-10", "25021-162-24"], "is_original_packager": [true], "unii": ["G0V6C994Q5"]}, "product_type": "Drugs", "event_id": "92678", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0935-2023", "product_description": "Oxacillin for Injection, USP, 1 gram per vial, For IV or IM Use, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  Made in India. NDC 25021-146-10.", "product_quantity": "65,710 vials for 1 g and 2 g strength", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230711", "center_classification_date": "20230721", "report_date": "20230802", "code_info": "Lot: OXG301, Exp 12/31/2025"}, {"status": "Terminated", "city": "Missoula", "state": "MT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71275", "recalling_firm": "Montana Compounding Pharmacy", "address_1": "111 N Higgins Ave", "address_2": "N/A", "postal_code": "59802-4437", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MT and ND", "recall_number": "D-1128-2015", "product_description": "Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT", "product_quantity": "1/5 mL vial", "reason_for_recall": "Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection", "recall_initiation_date": "20150515", "center_classification_date": "20150609", "termination_date": "20161220", "report_date": "20150617", "code_info": "Lot 04062015:18@1.  Expiry date: 8/1/2015"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0305-2023", "product_description": "Methylprednisolone 12MG IN NS 1.2ML SYRINGE, steroid, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "27 syringes", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 29-31, 2022"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77450", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL", "recall_number": "D-0925-2017", "product_description": "Walgreens Daytime and Nighttime Cold & Flu, packaged in combo pack of two plastic 12FL OZ (355 mL) bottles connected by one paper sleeve, TOTAL 24 FL OZ (1.5 pt)(710 mL), OTC, Distributed by: Walgreen CO., 200 Wilmot Rd., Deerfield, IL 60015", "product_quantity": "1,998 combo packs", "reason_for_recall": "Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for \u001cDay-Night Cold and Flu\u001d whereas the batch contains Day-Night Cough Liquid.", "recall_initiation_date": "20170605", "center_classification_date": "20170628", "termination_date": "20171207", "report_date": "20170705", "code_info": "Lot #: 6MV0944, Exp 10/18"}, {"status": "Terminated", "city": "Woodbine", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["B FORCE"], "generic_name": ["ECHINACEA ANGUSTIFOLIA, LOMATIUM DISSECTUM, MYRRHA, NASTURTIUM AQUATICUM, TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, PROPOLIS, GLANDULA SUPRARENALIS SUIS, LYMPH NODE (SUIS), SPLEEN (SUIS), THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BELLADONNA, HYPERICUM PERFORATUM, PHOSPHORUS, BOTULINUM, COLIBACILLINUM CUM NATRUM MURIATICUM, PROTEUS (VULGARIS), PSEUDOMONAS AERUGINOSA, PROTEUS (MORGANI), SALMONELLA TYPHI NOSODE, CLOSTRIDIUM PERFRINGENS"], "manufacturer_name": ["BioActive Nutritional, Inc."], "product_ndc": ["43857-0576"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ARSENIC TRIOXIDE", "ATROPA BELLADONNA", "BOTULINUM TOXIN TYPE A", "CLOSTRIDIUM PERFRINGENS", "ECHINACEA ANGUSTIFOLIA WHOLE", "ESCHERICHIA COLI", "GOLDENSEAL", "HANDROANTHUS IMPETIGINOSUS BARK", "HYPERICUM PERFORATUM WHOLE", "LOMATIUM DISSECTUM ROOT", "MYRRH", "NASTURTIUM OFFICINALE", "PHOSPHORUS", "PROPOLIS WAX", "PROTEUS MORGANII", "PROTEUS VULGARIS", "PSEUDOMONAS AERUGINOSA", "SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI", "SUS SCROFA ADRENAL GLAND", "SUS SCROFA LYMPH", "SUS SCROFA SPLEEN", "SUS SCROFA THYMUS", "SUS SCROFA THYROID"], "spl_id": ["876c09b2-e376-44d0-bf4d-e25857e8595d"], "spl_set_id": ["2eb4e898-4019-425a-9ef9-536f112b88f0"], "package_ndc": ["43857-0576-1"], "is_original_packager": [true], "nui": ["N0000175771", "N0000193962", "N0000175731", "N0000175770"], "pharm_class_epc": ["Acetylcholine Release Inhibitor [EPC]", "Neuromuscular Blocker [EPC]"], "pharm_class_pe": ["Neuromuscular Blockade [PE]"], "pharm_class_moa": ["Acetylcholine Release Inhibitors [MoA]"], "unii": ["S7V92P67HO", "WQZ3G9PF0H", "E211KPY694", "OVP6XX033E", "VB06AV5US8", "514B9K0L10", "ZW3Z11D0JV", "6GLA1946WX", "XK4IUX8MNB", "5329928G5N", "JC71GJ1F3L", "YH89GMV676", "27YLU75U4W", "6Y8XYV2NOF", "56X6LID5ZY", "11T9HCO30O", "Y793W5V55N", "760T5R8B3O", "398IYQ16YV", "33A7VYU29L", "92AMN5J79Y", "7B69B0BD62", "6RV024OAUQ"]}, "product_type": "Drugs", "event_id": "88182", "recalling_firm": "Grato Holdings, Inc.", "address_1": "201 Apple Blvd", "address_2": "", "postal_code": "51579-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "FL", "recall_number": "D-0653-2021", "product_description": "B-Force, Homeopathic, 1 Fl Oz (30 mL) bottle, Distributed by: BioActive Nutritional, Inc., Melbourne, FL 32935, NDC 43857-0576-1", "product_quantity": "1480 bottles", "reason_for_recall": "Superpotent", "recall_initiation_date": "20210618", "center_classification_date": "20210712", "termination_date": "20221018", "report_date": "20210721", "code_info": "Lot: Z61917", "more_code_info": ""}, {"status": "Terminated", "city": "Clarence", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89779", "recalling_firm": "Athenex Pharma Solutions, LLC", "address_1": "11342 Main St", "address_2": "N/A", "postal_code": "14031-1718", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0711-2022", "product_description": "Phenylephrine HCl Injection in 0.9% Sodium Chloride, 20 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-491-15", "product_quantity": "1,980 bags", "reason_for_recall": "Defective container", "recall_initiation_date": "20220314", "center_classification_date": "20220321", "termination_date": "20220804", "report_date": "20220330", "code_info": "Lot #: F2101654, Exp 5/30/22; F2101834, Exp 7/03/22; F2200110, Exp 7/27/22"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "24 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;    03092015@49, 9/5/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Nandrolone Decanoate 250 mg/ml Injection, ml Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1617-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:  0383652    0383653    0383653    0383652    0383652    0383651    0383651", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/LIDOCAINE/METHYLPREDNISOLONE 0.17% / 0.67% / 2.7% INJECTABLE 15 ML, 18.75 ML, 26.25 ML, 37.5 ML, 45 ML; BUPIVACAINE/LIDOCAINE/METHYLPREDNISOLONE 0.22% / 0.88% / 0.88% INJECTABLE 450 ML, 900 ML (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1477-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0689-2020", "product_description": "BUP 2.5MG/ CLONI 5MCG/ FENT 200MCG/ SUF 50MCG/ML (40)  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "2 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@4 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0162-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 2MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "6 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1009222021:34 BUD: 03/21/2022; T1008022021:71 BUD: 01/29/2022; T1006072021:73 BUD: 12/04/2021", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "60 Cases", "code_info": "Product Code: 6914-S; Lots: 52435, EXP 10/03/2017, 57750, EXP 09/18/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q.Care Oral Cleansing & Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse q4. Contains 1 Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse,  4 Suction Oral Swab packages with Perox-A-Mint solution, 2 Suction Oral Swab packages with Alcohol-Free Mouthwash, 4 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6914-S UPC 6 18029 83017 3", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0401-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63971", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-133-2013", "product_description": "PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.", "product_quantity": "60,289 bottles", "reason_for_recall": "Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.", "recall_initiation_date": "20121205", "center_classification_date": "20130118", "termination_date": "20140516", "report_date": "20130130", "code_info": "Lot #: 68581A, 68581B, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68582A, 68582B, Exp 01/15"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68191", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States: TX, IL, MD, IN", "recall_number": "D-1567-2014", "product_description": "Glycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only.  Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville, IN 46060,  NDC#: 45183-0965-70.", "product_quantity": "200 Syringes", "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.", "recall_initiation_date": "20140421", "center_classification_date": "20140826", "termination_date": "20141203", "report_date": "20140903", "code_info": "Lot #: E131210.212 Exp: 07/14/2014"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "55", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Bupivacaine HCI 0.125% in 0.9% Sodium Chloride,  250 mL  lntravia bag, Rx Only,Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060,  NDC 45183-0909-02", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1321-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Parsippany", "address_1": "400 Interpace Pkwy", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).", "address_2": "", "product_quantity": "672 bottles", "code_info": "L503092, Exp 04/2016", "center_classification_date": "20160824", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NJ", "product_description": "Acetasol HC (hydrocortisone and acetic acid otic solution USP) , Rx Only, 10 mL bottle, Manufactured by: Actavis Midatlantic LLC 1877 Kawai Road Lincolnton, NJ 28092 USA, NDC 0472-0882-82", "report_date": "20160831", "classification": "Class III", "openfda": {}, "recalling_firm": "Actavis Inc", "recall_number": "D-1471-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74902", "termination_date": "20170208", "more_code_info": "", "recall_initiation_date": "20160802", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]